Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
发明人:
Daniel-Christoph WAGNER,Claudia PÖSEL,Gesa WEISE
申请号：
US15317789
公开号：
US20170128537A1
申请日:
2015.06.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to Granulocyte colony-stimulating factor (GCSF) for use in the treatment of neurogenic immune depression syndrome, for use in the prevention of mortality after brain injury and for use in the prevention of brain inflammation after brain injury.
